ESPE 2014


Our coverage of ESPE 2014, in Dublin, included symposia devoted to diabetes, obesity and hypoadrenalism, and the latest findings from a clinical trial of asfotase alfa in hypophosphatasia. Click through for the reports, as well as expert interviews with Jovanna Dahlgren, Krishna Chatterjee and Moshe Phillip.

Expert interviews

Professor Jovanna Dahlgren (Gothenburg University, Sweden) talks to medwireNewsFocus about her decade of clinical experience using prediction models to optimise growth hormone treatment in prepubertal children.

Professor Moshe Phillip (Tel Aviv University, Israel) talks to medwireNews Focus about a wireless fully automated closed-loop system for the control of diabetes, and how it provides a potent tool for lowering the rate of nocturnal hypoglycaemia and improving overall glucose control.

Professor Krishna Chatterjee (Professor of Endocrinology, University of Cambridge, UK) talks to medwireNews Focus about new forms of thyroid resistance that are particularly relevant to paediatric endocrine practice, and how the identification of these disorders could impact on future therapy decisions. To contact the team about rare clinical case diagnoses seen in your own practice, please email Professor Chatterjee at or Dr Carla Moran at

News highlights

ESPE 2014 Highlights: Day One

Opening the morning’s Working Group Session on diabetes technology and therapeutics, Moshe Phillip (Schneider Children's Medical Center of Israel, Petah Tikva) noted that there has been “traditionall [...]

ESPE 2014 Highlights: Day Two

The second day of ESPE 2014 saw the first of the new research communications, with sessions including adrenal, diabetes, growth and neuroendocrinology. Transforming life quality in HPP Another of thes [...]

ESPE 2014 Highlights: Day Three

The final day of ESPE 2014 shone the spotlight on obesity, starting with the first of the day’s plenary lectures given by Donal O’Shea (St Vincent’s University Hospital, Dublin, Ireland). Prevention b [...]

Go to Top